A 49-year-old unsigned commentary in The Lancet that’s been used in litigation to prop up the safety of talc products has been retracted after it was revealed the author was a paid consultant to Johnson & Johnson at the time it was written. (Retraction Watch)
Researchers are now able to identify why some veterans exposed to Agent Orange during the Vietnam War develop severe bone marrow cancers. (University of Miami Miller School of Medicine)
The Society for Immunotherapy of Cancer published updated clinical practice guidelines for the treatment of renal cell carcinoma.
Organ size may be linked to cancer risk in individuals with obesity. (Cancer Research)
A machine-learning model accurately predicted hepatocellular carcinoma risk by analyzing blood test results and routinely collected electronic health record data. (Cancer Discovery)
With the blockade of the Strait of Hormuz, should MRI providers start worrying about helium shortages? (Radiology Business)
A phase II study of tumor treating fields combined with atezolizumab (Tecentriq) and chemotherapy as first-line treatment for pancreatic cancer met its primary endpoint, with an improved disease control rate versus a historical comparator, Novocure announced.
The FDA approved updated labeling to allow a 25-minute thaw time for nadofaragene firadenovec (Adstiladrin), a treatment for bladder cancer, Ferring Pharmaceuticals announced.
A breast cancer patient in Vermont filed a class action lawsuit against Novartis, alleging the company shared personal health data to Google and other tech companies through the use of web activity trackers. (Health Exec)
In other legal news, an Alabama doctor was sentenced to 16 months in prison and ordered to pay $2.7 million in restitution for a fraud scheme that included unnecessary genetic testing used to detect higher cancer risk, according to the Justice Department.
A one-time low-dose CT screening exam can significantly reduce lung cancer mortality in never smokers, according to research presented at the European Lung Cancer Congress. (European Society for Medical Oncology)
The phase III SENTRY trial testing selinexor (Xpovio) in combination with ruxolitinib (Jakafi) in frontline myelofibrosis met one of its co-primary endpoints, said Karyopharm Therapeutics.
Leonid Radvinsky, the billionaire founder of the adult content platform OnlyFans, died of cancer at the age of 43. (Fortune)
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/120532
Author :
Publish date : 2026-03-27 19:38:00
Copyright for syndicated content belongs to the linked Source.
